A Real World Study of Apatinib in Treatment of Patients With Gastric Carcinoma
The study was designed to evaluate the efficacy and safety of apatinib in the treatment of patients with gastric carcinoma.
Gastric Carcinoma
Overall Survival, Overall Survival, 2015-2018
Objective Response Rate, Objective Response Rate, 2015-2018|Disease Control Rate, Disease Control Rate, 2015-2018|Progression-Free Survival, Progression-Free Survival, 2015-2018
The study is a real-world non-interventional retrospective study and will collect the original medical records of patients with gastric carcinoma treated with apatinib from 2015 to 2018 in Henan Cancer Hospital. Clinical data such as patient demographic, history of treatments, tumor biological characteristics and adverse events will be analyzed to evaluate the efficacy and safety of apatinib and explore the risk factors of prognosis in patients with gastric carcinoma.